Diet for Hypoglycemia

Diet For Hypoglycemia Blood Sugar News

Press ReleaseMonday, June 28, 2010 @ 9:18AMMerck & Co. Inc. Posted on:28 Jun 10 In a new post-hoc analysis presented for the first time at the American Diabetes Association (ADA) 70th Annual Scientific Sessions, significantly more patients treated with the DPP-4 inhibitor JANUVIA (sitagliptin) for one year achieved a composite endpoint of A1C1 reduction (greater than 0.5 percent), no hypoglycemia and no weight gain compared with patients ...

In a Post-Hoc Analysis, JANUVIA® (sitagliptin), Merck's Diabetes Medicine, Compared with a Sulfonylurea (Glipizide) on ...Monday, June 28, 2010 @ 7:00AMWHITEHOUSE STATION, N.J.----In a new post-hoc analysis presented for the first time at the American Diabetes Association 70th Annual Scientific Sessions, significantly more patients treated with the DPP-4 inhibitor JANUVIA for one year achieved a composite endpoint of A1C1 reduction , no hypoglycemia and no weight gain compared with patients treated with glipizide, a commonly used sulfonylurea.

Roche reports results of 5 taspoglutide Phase III studies for type 2 diabetes at 70th ADAMonday, June 28, 2010 @ 5:38AMIpsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed ...

'Artificial pancreas' for diabetes is testing wellMonday, June 28, 2010 @ 4:54AMScientists are getting closer to offering an "artificial pancreas" to children and adults with type 1 diabetes that will help better control the swings of blood glucose that come with the disease.

Ipsen's partner Roche confirms the promising efficacy profile of TaspoglutideSaturday, June 26, 2010 @ 9:00AMPARIS----Regulatory News:

Diabetes Symptoms to Never IgnoreThursday, June 3, 2010 @ 3:36PMWebMD describes serious symptoms to watch out for if you have diabetes.

Researchers identify potential target for treatment of obesity-related diseasesWednesday, April 14, 2010 @ 1:45PMScientists from Eastern Virginia Medical School (EVMS) recently presented preliminary research findings that identify a specific gene as a potential new target for treating obesity-related diseases.